HCW Biologics (HCWB) Balance Sheet: Assets & Liabilities

HCW Biologics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for HCW Biologics Inc. (HCWB) - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Mar 2026	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	1.95	1.95	4.67	3.60	22.33	11.73	8.46	7.36
Short-Term Investments	0.00	-	0.00	0.00	9.74	24.98	0.00	0.00
Cash & Short-Term Investments	1.95	1.95	4.67	3.60	32.06	36.71	8.46	7.36
Accounts Receivable	0.03	0.03	0.58	1.54	0.42	0.13	2.50	0.00
Inventory	0.00	-	0.00	0.00	1.39	0.00	0.00	0.00
Other Current Assets	0.30	0.08	0.11	1.27	1.59	3.63	0.54	0.67
Total Current Assets	2.28	2.28	5.70	6.40	34.07	40.48	12.15	8.03
Non-Current Assets
Property, Plant & Equipment (Net)	20.88	20.88	22.91	20.45	10.80	1.12	1.62	2.00
Long-Term Investments	1.33	1.33	1.60	1.60	1.60	11.52	1.60	0.00
Other Non-Current Assets	0.03	0.03	0.03	0.06	0.33	0.39	0.03	0.03
Total Non-Current Assets	22.24	22.24	24.54	22.11	12.74	13.03	3.25	2.04
Total Assets	24.52	24.52	30.24	28.51	46.81	53.51	15.40	10.07
Current Liabilities
Accounts Payable	13.14	13.14	22.33	6.17	1.23	0.22	0.16	0.39
Short-Term Debt	6.81	6.81	6.31	0.12	0.00	0.00	0.57	0.00
Current Portion of Long-Term Debt	-	-	-	0.12	-	-	-	-
Accrued Liabilities	-	1.11	0.98	2.58	1.73	2.10	0.28	-
Deferred Revenue	0.00	-	0.00	0.00	0.00	1.80	0.00	0.00
Other Current Liabilities	1.11	-	0.98	2.58	1.73	0.30	0.28	0.67
Total Current Liabilities	21.06	21.06	29.63	8.75	2.96	2.32	1.00	1.07
Non-Current Liabilities
Long-Term Debt	0.00	-	7.38	6.30	6.41	0.00	0.00	0.00
Other Non-Current Liabilities	0.69	0.69	0.00	0.00	0.01	0.00	0.00	0.00
Total Non-Current Liabilities	0.69	0.69	7.38	6.30	6.42	0.00	0.00	0.00
Total Liabilities	21.76	21.76	37.01	15.05	9.38	2.32	1.00	1.07
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-108.52	-108.52	-100.56	-70.53	-45.54	-30.64	-16.72	-9.68
Accumulated Other Comprehensive Income	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Additional Paid-in Capital	111.28	111.28	93.79	83.99	82.96	81.83	0.00	0.00
Shares Outstanding	-	0.55	0.19	0.15	0.15	0.89	-	-
Total Stockholders' Equity	2.76	2.76	-6.77	13.46	37.43	51.19	14.40	9.00
Total Liabilities & Equity	24.52	24.52	30.24	28.51	46.81	53.51	15.40	10.07

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About HCW Biologics Balance Sheet

How much debt does HCW Biologics have?

HCW Biologics had total debt of $6.81M as of Mar 31, 2026, against $1.95M in cash and short-term investments. Its debt-to-equity ratio was 2.46. Total debt was $13.69M a year earlier.

What are HCW Biologics's total assets?

HCW Biologics reported total assets of $24.52M as of Mar 31, 2026, down 18.9% from $30.24M a year earlier. Total liabilities were $21.76M.

What is HCW Biologics's shareholders' equity?

HCW Biologics's shareholders' equity was $2.76M as of Mar 31, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition